Evidence map›Paper›PMID 17993265›Full record

ArticleCellular signalling2008

Kit- and Fc epsilonRI-induced differential phosphorylation of the transmembrane adaptor molecule NTAL/LAB/LAT2 allows flexibility in its scaffolding function in mast cells.

Shoko Iwaki, Jiri Spicka, Christine Tkaczyk, Bettina M Jensen, Yasuko Furumoto, Nicolas Charles, Martina Kovarova, Juan Rivera, Vaclav Horejsi, Dean D Metcalfe and 1 more

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. KIT as a master regulator of the mast cell lineage.The Journal of allergy and clinical immunology · 2022
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Signal transduction and chemotaxis in mast cells.European journal of pharmacology · 2016
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Immunoglobulin E receptor signaling and asthma.The Journal of biological chemistry · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Shoko IwakiLaboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 10 Center Drive, MSC 1881, Bethesda, MD 20892-1881, USA.
Jiri Spicka
Christine Tkaczyk
Bettina M Jensen
Yasuko Furumoto
Nicolas Charles
Martina Kovarova
Juan Rivera
Vaclav Horejsi
Dean D Metcalfe
Alasdair M Gilfillan
National Institute of Arthritis and Musculoskeletal and Skin Diseases · USNational Institutes of Health · USCzech Academy of Sciences · CZNational Institute of Allergy and Infectious Diseases · US

Funding

INTRACELLULAR SIGNALING BY THE CELL SURFACE RECEPTOR FOR IGEZ01AR041101 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI RIVERA, JUAN · 1995 to 2008
$2.7M
Integrated Signaling Pathways for the Enhancement of Mast Cell ActivationZ01AI000965 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI METCALFE, DEAN D · 2006 to 2008
$772k
Intramural NIH HHS Z01 AI000965
6 · The paper itself

Abstract

The transmembrane adaptor protein (TRAP), NTAL, is phosphorylated in mast cells following FcvarepsilonRI aggregation whereby it cooperates with LAT to induce degranulation. The Kit ligand, stem cell factor (SCF), enhances antigen-induced degranulation and this also appears to be NTAL-dependent. However, Kit and FcvarepsilonRI appear to utilize different mechanisms to induce NTAL phosphorylation. Thus, we examined whether the responsible kinases selectively phosphorylated distinct tyrosines in NTAL and explored the implications for downstream signaling. Whereas FcvarepsilonRI required Lyn and Syk for NTAL phosphorylation, Kit appeared to directly phosphorylate NTAL. Furthermore, co-transfection studies with NTAL constructs revealed that Lyn, Syk, and Kit phosphorylate different tyrosines in NTAL. The tyrosines principally phosphorylated by Syk were recognized as Grb2-binding sites, whereas Lyn and Kit phosphorylated other tyrosines, both inside and outside of these motifs. Pull down studies revealed that PLCgamma1 associated with the two terminal Syk-phosphorylated Grb2-binding sites, which would help to explain the observed decrease in antigen-induced calcium signal and degranulation in NTAL-knock down-human mast cells. The observations reported herein support the conclusion that NTAL may be differentially utilized by specific receptors for relaying alternative signals and this suggests a flexibility in the function of TRAPs not previously appreciated.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCells, CulturedCytoskeletonHumansIntracellular Signaling Peptides and ProteinsMast CellsMiceMice, Inbred C57BLMice, KnockoutPhospholipase C gammaPhosphorylationProtein-Tyrosine KinasesReceptors, IgEsrc-Family KinasesStem Cell FactorAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsLAT2 protein, humanlyn protein-tyrosine kinasePhospholipase C gammaProtein-Tyrosine KinasesReceptors, IgEsrc-Family KinasesStem Cell FactorSyk KinaseSYK protein, humanSyk protein, mouse

Identifiers

PMID17993265
PMCPMC2329585
OpenAlexW2102174567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.